UBS O'Connor’s iRhythm Holdings IRTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-7,993
Closed -$1.23M 372
2025
Q2
$1.23M Sell
7,993
-5,513
-41% -$712K 0.03% 190
2025
Q1
$1.41M Sell
13,506
-5,685
-30% -$602K 0.03% 153
2024
Q4
$1.73M Sell
19,191
-5,535
-22% -$435K 0.04% 172
2024
Q3
$1.84M Buy
24,726
+6,379
+35% +$508K 0.05% 188
2024
Q2
$1.97M Sell
18,347
-600
-3% -$61.3K 0.06% 195
2024
Q1
$2.2M Sell
18,947
-1,400
-7% -$157K 0.06% 159
2023
Q4
$2.18M Sell
20,347
-811
-4% -$70.7K 0.07% 160
2023
Q3
$1.99M Buy
21,158
+8,629
+69% +$877K 0.04% 240
2023
Q2
$1.31M Sell
12,529
-3,186
-20% -$383K 0.03% 355
2023
Q1
$1.95M Buy
+15,715
New +$1.7M 0.05% 318

Other funds holding IRTC

UBS O'Connor's IRTC Position: Q3 2025 in Review

UBS O'Connor sold out of iRhythm Holdings (IRTC) in Q3 2025, closing a stake of 7,993 shares — an estimated $1.23M sold.

UBS O'Connor first reported a position in IRTC in Q1 2023 and held it in 10 quarters. The position peaked at $2.2M in Q1 2024. 337 funds tracked by Wall St. Rank hold IRTC as of Q3 2025.

  • UBS O'Connor reported no remaining iRhythm Holdings position as of Q3 2025 after selling out during the quarter.
  • UBS O'Connor sold 7,993 iRhythm Holdings shares in Q3 2025, an estimated $1.23M.
  • UBS O'Connor first reported a position in iRhythm Holdings in Q1 2023 and held it in 10 quarters.
  • UBS O'Connor's iRhythm Holdings position peaked at $2.2M in Q1 2024.
  • 337 funds tracked by Wall St. Rank held iRhythm Holdings as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.